MoneyWorks4Me

Genomic Valley Biotech informs about disclosure

18 Oct 2024 Evaluate
Genomic Valley Biotech has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Parul Agrawal.

The above information is a part of company’s filings submitted to BSE.
Peers